In this study, 513 CRC tumor samples were divided into 3 categories, namely, cluster 1 (n = 203), cluster 2 (n = 296), and cluster 3 (n = 296), based on the expression levels of the CCGs (Figure 2(a)). This evidence concerns the gene TAF1 and colorectal carcinoma.